Class II · Moderate risk
Pantoprazole Sodium Dr
Labeling: Label Mixup; PANTOPRAZOLE SODIUM DR, Tablet, 20 mg may be potentially mislabel as NORTRIPTYLINE HCL, Capsule, 75 mg, NDC 00093081301, Pedigree: W003694, EXP: 6/26/2014.
Is Pantoprazole recalled?
Yes — there is an active recall. 3 ongoing FDA recalls mention Pantoprazole (27 total). Check the affected lots below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Pantoprazole. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Pantoprazole recalls on record
none so far in 2026; 27 on record, newest first
Class II · Moderate risk
Pantoprazole Sodium Delayed Release Tablets USP
cGMP Deviations: Oral products were not manufactured in accordance with Good Manufacturing Practices.
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.